Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check20 days agoChange DetectedThe page continues to display a 403 Forbidden error instead of the clinical-trial record. A general NIH website transition notice has been added, and the site revision advances to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier updates from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page previously displayed a 403 error and now shows the actual study details content for the NCT04181788 record, restoring access to the ClinicalTrials.gov entry.SummaryDifference0.5%

- Check48 days agoChange DetectedA 403 Forbidden page now appears at the study URL, replacing the study record and its associated details. The visible content shifts to the error notice and site footer, signaling restricted access to the study information.SummaryDifference18%

- Check55 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This update appears to reflect a version control change rather than any clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.